Evaluation of de novo donor specific antibodies after kidney transplantation in the era of donor-derived cell-free DNA
BackgroundDonor-derived cell-free DNA (dd-cfDNA) is a promising non-invasive biomarker for detecting graft injury in solid organ transplant recipients. Elevated dd-cfDNA levels are strongly associated with rejection and graft injury, especially antibod…